Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment.

Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment.

Item
http://www.wikidata.org/entity/Q33954583
Influence of Renal Impairment on the Pharmacokinetics of Afatinib: An Open-Label, Single-Dose Study.Simultaneous and rapid determination of gefitinib, erlotinib and afatinib plasma levels using liquid chromatography/tandem mass spectrometry in patients with non-small-cell lung cancer.A highly efficient and sensitive LC-MS/MS method for the determination of afatinib in human plasma: application to a metabolic stability study.Efficacy of afatinib, an irreversible ErbB family blocker, in the treatment of intracerebral metastases of non-small cell lung cancer in mice.Clinical Pharmacokinetics and Pharmacodynamics of Afatinib.Epidermal growth factor receptor tyrosine kinase inhibitors in elderly patients with non-small cell lung cancer.Afatinib in squamous cell carcinoma of the head and neck.A tag-free collisionally induced fragmentation approach to detect drug-adducted proteins by mass spectrometry.Afatinib Decreases P-Glycoprotein Expression to Promote Adriamycin Toxicity of A549T Cells.Investigation of the impact of hepatic impairment on the pharmacokinetics of dacomitinib.
P2860

Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment.

Item
http://www.wikidata.org/entity/Q33954583
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment.
@ast
Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment.
@en
type
label
Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment.
@ast
Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment.
@en
prefLabel
Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment.
@ast
Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P932